(Q36736188)

16 August 2017

1 reference

title

The target tissue in autoimmunity--an influential niche (English)

1 reference

16 August 2017

author

Malin Flodström-Tullberg

4

object named as

Malin Flodström-Tullberg

0 references

Monica Hultcrantz

2

object named as

Monica Hultcrantz

0 references

author name string

Natasha J Hill

1

1 reference

16 August 2017

Monica Hultcrantz

2

1 reference

16 August 2017

Nora Sarvetnick

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

European Journal of Immunology

16 August 2017

published in

1 reference

16 August 2017

volume

37

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

589-597

1 reference

Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

Toward biomarkers in multiple sclerosis: new advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Genes, environment and immunity in the development of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Genetic control of autoimmune diabetes in the NOD mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Suppressors of cytokine signaling and immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

The many roles of chemokines and chemokine receptors in inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Interleukin-15: a new cytokine target for the treatment of inflammatory diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Interleukin 15 mediates epithelial changes in celiac disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Myocytes respond in vivo to an antibody reactive with the acetylcholine receptor by upregulating interleukin-15: an interferon-gamma activator with the potential to influence the severity and course of experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Beta cell MHC class I is a late requirement for diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Expression of transporter associated with antigen processing-1 in the endocrine cells of human pancreatic islets: effect of cytokines and evidence of hyperexpression in IDDM.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Proteasome subunits, low-molecular-mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin-dependent diabetes mellitus: implications for autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Progression of autoimmune diabetes driven by avidity maturation of a T-cell population

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Cytotoxic T-Cells From T-Cell Receptor Transgenic NOD8.3 Mice Destroy β-Cells via the Perforin and Fas Pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Roles of the NKG2D immunoreceptor and its ligands

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

NKG2D blockade prevents autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

CD200 and membrane protein interactions in the control of myeloid cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Control of myeloid activity during retinal inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Projection of an immunological self shadow within the thymus by the aire protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

FOXP3 acts as a rheostat of the immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Role of PTPN22 in type 1 diabetes and other autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Insulin-dependent diabetes loci Idd5 and Idd9 increase sensitivity to experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Enteroviruses: new findings on the role of enteroviruses in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Target cell defense prevents the development of diabetes after viral infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Particularities of the vasculature can promote the organ specificity of autoimmune attack.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Dynamic visualization of a joint-specific autoimmune response through positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Citrullination: a small change for a protein with great consequences for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Citrullination: a posttranslational modification in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Complement, natural antibodies, autoantibodies and tissue injury

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Citrullinated proteins in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Coeliac disease: dissecting a complex inflammatory disorder

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Oxidatively modified autoantigens in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: Celiac Disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Association between PADI4 and rheumatoid arthritis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Resistance of the target islet tissue to autoimmune destruction contributes to genetic susceptibility in Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636368

7 January 2021

Identifiers

DOI

10.1002/EJI.200636368

1 reference

16 August 2017

1 reference